These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38456261)

  • 21. New concepts in hypertrophic cardiomyopathies, part I.
    Roberts R; Sigwart U
    Circulation; 2001 Oct; 104(17):2113-6. PubMed ID: 11673355
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypertrophic cardiomyopathy in 2012.
    Ho CY
    Circulation; 2012 Mar; 125(11):1432-8. PubMed ID: 22431884
    [No Abstract]   [Full Text] [Related]  

  • 23. Natural history of hypertrophic cardiomyopathy.
    Elliott PM
    Curr Cardiol Rep; 2000 Mar; 2(2):141-7. PubMed ID: 10980885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How should hypertrophic cardiomyopathy be classified?: Molecular diagnosis for hypertrophic cardiomyopathy: Not ready for prime time.
    Elliott P; McKenna WJ
    Circ Cardiovasc Genet; 2009 Feb; 2(1):87-9; discussion 89. PubMed ID: 20031570
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypertrophic cardiomyopathy--beyond the sarcomere.
    St John Sutton M; Epstein JA
    N Engl J Med; 1998 Apr; 338(18):1303-4. PubMed ID: 9562586
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy.
    Garfinkel AC; Seidman JG; Seidman CE
    Heart Fail Clin; 2018 Apr; 14(2):139-146. PubMed ID: 29525643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contemporary trends of genetic analysis in hypertrophic cardiomyopathy].
    Belenkov IuN; Privalova EV; Kaplunova VIu; Khabarova NV; Shakar'iants GA
    Kardiologiia; 2012; 52(11):42-7. PubMed ID: 23237395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility gene card for: hypertrophic cardiomyopathy (type 1-14).
    Pinto YM; Wilde AA; van Rijsingen IA; Christiaans I; Deprez RH; Elliott PM
    Eur J Hum Genet; 2011 Aug; 19(8):. PubMed ID: 21267010
    [No Abstract]   [Full Text] [Related]  

  • 29. Comprehensive Genetic Testing for Pediatric Hypertrophic Cardiomyopathy Reveals Clinical Management Opportunities and Syndromic Conditions.
    Gal DB; Morales A; Rojahn S; Callis T; Garcia J; Priest JR; Truty R; Vatta M; Nussbaum RL; Esplin ED; Hollander SA
    Pediatr Cardiol; 2022 Mar; 43(3):616-623. PubMed ID: 34714385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenicity of Hypertrophic Cardiomyopathy Variants: A Path Forward Together.
    Ingles J; Burns C; Funke B
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 28986458
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypertrophic cardiomyopathy.
    Ho CY
    Heart Fail Clin; 2010 Apr; 6(2):141-59. PubMed ID: 20347784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic basis of hypertrophic cardiomyopathy.
    Lind JM; Chiu C; Semsarian C
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):927-34. PubMed ID: 17173506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy.
    Ho CY
    Circulation; 2010 Dec; 122(23):2430-40; discussion 2440. PubMed ID: 21135371
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical Profile and Health Disparities in a Multiethnic Cohort of Patients With Hypertrophic Cardiomyopathy.
    Butters A; Semsarian CR; Bagnall RD; Yeates L; Stafford F; Burns C; Semsarian C; Ingles J
    Circ Heart Fail; 2021 Mar; 14(3):e007537. PubMed ID: 33724884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy.
    Lakdawala NK; Olivotto I; Day SM; Han L; Ashley EA; Michels M; Ingles J; Semsarian C; Jacoby D; Jefferies JL; Colan SD; Pereira AC; Rossano JW; Wittekind S; Ware JS; Saberi S; Helms AS; Cirino AL; Leinwand LA; Seidman CE; Ho CY
    Circ Genom Precis Med; 2021 Feb; 14(1):e003062. PubMed ID: 33284039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why should cardiologists consider genetic testing for hypertrophic cardiomyopathy?
    Judge DP
    JACC Heart Fail; 2015 Feb; 3(2):189-91. PubMed ID: 25543975
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
    Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
    Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modern genetic counselling : Practical aspects exemplified by hypertrophic cardiomyopathy].
    Czepluch F; Hasenfuß G; Wollnik B
    Internist (Berl); 2018 Aug; 59(8):790-798. PubMed ID: 29943241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinguishing hypertrophic cardiomyopathy-associated mutations from background genetic noise.
    Kapplinger JD; Landstrom AP; Bos JM; Salisbury BA; Callis TE; Ackerman MJ
    J Cardiovasc Transl Res; 2014 Apr; 7(3):347-61. PubMed ID: 24510615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.